Targeted treatment technology wins award
(11 January 2019)
A Durham University spin out-company, led by academics in our Chemistry and Biosciences departments, has been recognised for its excellence at a regional awards ceremony.
LightOx Ltd develops treatments to target unwanted cells, such as cancer cells, in the body.
The company celebrated as they received the award for start-up of the year at the Bionow Awards.
The awards recognise quality, outstanding achievement and enterprise in the North of England’s Life Sciences sector. The sector is currently worth more than £13 billion to the regional economy annually.
LightOx Ltd treatments target unwanted cells in the body, which could provide alternative treatments for infections, wounds and even cancerous cells, potentially avoiding surgery or the use or antibiotics.
The technology works by ‘lighting up’ specific damaged cells with a fluorescent tag in areas such as primary and secondary tumour regions. This tagging technology could then both selectively and effectively eliminate tumour cells without causing significant disruption to non-cancerous tissue and surrounding healthy cells.
LightOx Ltd was founded in 2016 to commercialise research developed by our departments of Chemistry and Biosciences, in partnership with the University of York and North East-based company, High Force Research Ltd.
Since 1997, over 40 companies have spun out from Durham. Our academics and investors have worked closely to commercialise research ideas, with over 1,000 jobs created as a result.